Then don't f'ing get it. It's real simple, non vaxxers

New Post Public Reply Private Reply Replies (2) Message Board
Bhawks copytele #62895
195
Then don't f'ing get it.

It's real simple, non vaxxers will mix with non vaxxers and there will be fewer and fewer GOP voters before we know it.

Vaxxed people can mix with anybody. I'll be one of those people a week from tomorrow.

Are you going against the grain in your state?


Here’s what epidemiologists know so far about Alaska’s COVID-19 ‘vaccine breakthrough’ cases

https://www.adn.com/alaska-news/2021/04/29/he...ugh-cases/

pencil Author: Annie Berman
clock Updated: 1 hour ago
calendar Published 4 hours ago

A relatively small group of Alaskans who were fully vaccinated against COVID-19 have since tested positive for the coronavirus.

They are referred to as “vaccine breakthrough” cases — and are rare compared to the total number of people fully vaccinated, health officials say. By late last week, 310 breakthrough cases had been detected in Alaska, out of the more than 250,000 Alaskans who are considered fully vaccinated.

A new report released this week by the state health department analyzed the first 152 breakthrough COVID-19 cases identified in Alaska between February and March.

The report shows that the vast majority of the breakthrough cases in Alaska have so far been mild or asymptomatic — which aligns with evidence that show the vaccines to be particularly effective at preventing severe illness and death.

The results of the report also underscore the fact that “it’s very, very uncommon to have vaccine breakthrough cases,” said Dr. Joe McLaughlin, state epidemiologist with the Alaska Department of Health and Social Services, during a call with reporters Thursday.

A small number of vaccine breakthrough cases are expected because “no vaccines are 100% effective at preventing illness,” according to a CDC webpage on vaccine breakthroughs. “There will be a small percentage of people who are fully vaccinated who still get sick, are hospitalized, or die from COVID-19,” the CDC said.

In clinical trials, the three currently available COVID-19 vaccines from Johnson & Johnson, Moderna and Pfizer were about 66%, 94% and 95% effective, respectively, at preventing symptomatic COVID-19.
[She got COVID-19, got vaccinated - and then got COVID again]

Over half of the 152 cases investigated in the Alaska report involved people who were asymptomatic for the entire course of their isolation periods. Nine percent were asymptomatic at the time of testing but later developed at least one symptom of the virus, and about a quarter were symptomatic at the time of testing.

One person with a breakthrough case in the state needed to be hospitalized, and one died, the report said. Both people had pre-existing conditions that put them at a heightened risk for severe illness for COVID-19.

“Their COVID diagnosis wasn’t a singular event that caused their hospitalization, or caused their death,” Dr. Louisa Castrodale, an epidemiologist with the state health department who helped compile the report, said Wednesday.

The majority of the cases were identified through routine, asymptomatic testing, including during travel, or before a health procedure or admit.

Alaska’s number of vaccine breakthrough cases during the time frame the report was conducted was somewhat high compared to other states, health officials said.

Partially, this was because Alaska has been conducting on average about three times as much COVID-19 testing compared to the national average — and Alaska was initially ahead of the curve with its vaccine rollout, said Dr. Anne Zink, the state’s chief medical officer, on Wednesday.


“We were testing a lot more people, and we had a lot more vaccinated,” she said. “So I think it’s important to understand how Alaska is a little different when you’re comparing these numbers to national numbers.”

The report includes a list of public health recommendations and reminders that align with recent CDC guidance for fully vaccinated people:

• Testing is no longer recommended for asymptomatic vaccinated people who are close contacts of someone with COVID-19, or who travel.

• Anyone with COVID-19 symptoms should get tested immediately regardless of their vaccination status.

• Anyone infected with COVID-19 must follow standard isolation procedures, regardless of their vaccination status.


• Those 16 and older should get vaccinated against COVID-19.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

UBCF Extends Pink Bag Event for Breast Cancer Aid

Updated Category News Views 2

Community Need Drives Event Extension October in Jonesboro just got a bit more hopeful for breast cancer survivors—it's not just about awareness anymore; it's about action. The United Breast Cancer Foundation (UBCF) has decided to extend its popular Pink Bag free shopping event through October 30th. What spurred this decision? Well, the overwhelming community demand,...

Continue Reading
AI Tool circMAC Enhances MicroRNA Mapping on circRNAs

Updated Category News Views 3

Mapping the Complex Maze of MicroRNA on Circular RNAs Pusan National University's brainiacs have cooked up something spicy for the bioinformatics world. They've developed this snazzy AI tool, circMAC, to unravel microRNA binding mysteries on circular RNAs. 'Why’s this such a big deal?' you ask. Well, these loop-shaped critters, circRNAs, play a backstage role in gene...

Continue Reading
Podium Surges Past $150M in AI ARR Milestone

Updated Category News Views 3

A New Era for Podium When the brass at Podium made a gamble on AI, they didn't just try squeezing it into their old business model. Oh no, they launched what feels like a startup within their existing empire—no half-measures, just full-throttle ambition. Fast forward two and a half years, and they've racked up over $150 million in annual recurring revenue from these...

Continue Reading
Labcorp, FDA Collaborate to Tackle Drug Abuse Risks

Updated Category News Views 2

Rethinking How We Evaluate Drug Abuse Potential Sometimes, the finance world gets a peek into something that ain't just about the numbers on a screen, something with real stakes beyond the bulls and bears. Labcorp's just thrown its hat in with the FDA and Charles River Laboratories in a collaboration that goes beyond just lining pockets. They're setting up to dissect how...

Continue Reading
Vertice P2P Aims to Transform Procurement Efficiency

Updated Category News Views 9

Vertice Dives Deeper into the Procurement Game Grab a coffee and let's talk some procurement—one of the least sexy, yet utterly essential parts of any operation. Vertice's latest announcement is anything but mundane. They're spiraling deeper into the procurement universe with their new Procure-to-Pay (P2P) capability, a bold expansion from their Intake-to-Procure (I2P)...

Continue Reading
Cognizant AI Nexus Aims to Tame Enterprise AI Chaos

Updated Category News Views 5

AI Investments Without Returns: The Current Scenario Well, wouldn't you know it? Enterprises have sunk a fortune into AI, and they're wagging their fingers once more at the mounting bills with little to show for it. Play the investment game long enough, and it seems you'll find the numbers don't always rub together and make sparks. This familiar tune of over-budget...

Continue Reading
TransPerfect Launches College Bowl Game in Puerto Rico

Updated Category News Views 2

Puerto Rico Welcomes College Football with Open Arms Imagine kicking towards the goalposts while the ocean breeze kisses your face—yep, that's what's happening in Puerto Rico this December. TransPerfect, a heavyweight in language and tech solutions, is rolling out the red carpet for the inaugural TransPerfect San Juan Bowl, and it’s not just a game. It’s a bold step...

Continue Reading
Carrier Drops $600M on U.S. Manufacturing Boost

Updated Category News Views 3

A Mighty Move in Manufacturing Carrier Global Corporation's recent muscle-flexing is something rarer than a golden goose in today's market—a $600 million thrust into beefing up U.S. manufacturing and engineering. You can't help but wonder if this is overzealous optimism or a meticulously calculated power play. Clocks don't tick this loudly without good reason, of...

Continue Reading
Innventure Investors Alert: Securities Investigation Looms

Updated Category News Views 6

Innventure's Murky Waters Just when you think you've seen it all, stuff like this reminds you nothing's safe in the market. The law folks at Stranch, Jennings & Garvey, PLLC are sniffing around Innventure, Inc. (NASDAQ: INV) like bloodhounds to see if there's been some hoodwinking going on. We're talking questions about funny business with a data center deal between...

Continue Reading
Xona's $250M Raise: GPS Transformation Sparks Debate

Updated Category News Views 5

The Satellite Race Heats Up: Xona's Ambitious Leap Hold onto your hats, folks, because Xona's making headlines with a $250 million infusion. This ain't just pocket change—it's part of a rocket-fueled mission to upend the GPS landscape. Imagine a world where GPS is 100 times stronger. That's the pitch, and folks, it's got the market buzzing. Valuation Rocketing: Investor...

Continue Reading

Top 5 Most Recently Viewed Articles

osapiens Attracts $100 Million Investment, Solidifying Unicorn Status

Updated Category News Views 125

osapiens Secures Major Funding Round osapiens, a leading firm in enterprise software dedicated to encouraging sustainable growth, has recently announced a significant financial milestone. The company has secured an impressive US$ 100 million in a Series C funding round, spearheaded by Decarbonization Partners, a collaboration between BlackRock and Temasek. This newfound...

Continue Reading
Microsoft Teams Partners with Thrive Global for Enhanced Wellbeing

Updated Category News Views 167

Microsoft and Thrive Global Join Forces for Employee Wellbeing Microsoft has embarked on an inspiring journey by partnering with Thrive Global, a company that specializes in behavior change strategies aimed at enhancing overall wellbeing. This collaboration aims to integrate a range of wellbeing resources seamlessly into the daily operations of Microsoft Teams, making it...

Continue Reading
Coventry First Challenges Abacus Lawsuit Over Life Settlements

Updated Category News Views 420

Coventry First LLC Files Motion to Dismiss Lawsuit Coventry First LLC, along with Co-Founder and Executive Chairman Alan H. Buerger, is taking a decisive stand against the lawsuit filed by Abacus Global Management, Inc. This move comes in response to a claim that Coventry believes lacks merit, particularly in light of recent industry changes. Key Developments Around the...

Continue Reading
AbbVie Announces Significant Dividend Increase for Shareholders

Updated Category News Views 222

AbbVie Declares Quarterly Dividend The board of directors at AbbVie Inc. (NYSE: ABBV) has announced a quarterly cash dividend of $1.55 per share. This decision reflects the company's ongoing commitment to providing value to its shareholders through dependable and substantial dividend distributions. Details and Timeline for the Dividend The announced dividend will be paid...

Continue Reading
GitLab's 'Ultimate' Strategy Drives Adoption and Stock Upgrades

Updated Category News Views 77

GitLab's Growing Demand for 'Ultimate' GitLab Inc (NASDAQ: GTLB) has recently experienced a notable uptick in the adoption of its 'Ultimate' offering, according to industry expert insights. The stock saw a boost when analyst Mike Cikos from Needham raised its rating from Hold to Buy, setting a price target of $70. This optimistic outlook is backed by GitLab's continued...

Continue Reading